Please check your internet connection and try again.
# Drug Information Request: Acetaminophen (Paracetamol)
## Overview
Acetaminophen is a non-opioid analgesic and antipyretic. It lacks significant anti-inflammatory properties and does not inhibit platelet aggregation. Its exact mechanism involves central inhibition of prostaglandin synthesis.
## Primary Indications
- Management of mild to moderate pain.
- Reduction of fever.
## Adult Dosing
- **Oral/IV:** 325 mg to 1000 mg every 4 to 6 hours.
- **Maximum Daily Dose:** 4,000 mg (4g) per 24 hours from all sources.
- **Caution:** Lower limits (typically 3,000 mg/day or less) are recommended for chronic use or adults with hepatic impairment.
## Pediatric Dosing
- **Oral/Rectal:** 10 to 15 mg/kg per dose every 4 to 6 hours.
- **IV (Age 2 years and older):** 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours.
- **Pediatric Maximum:** 75 mg/kg/day (not to exceed 4,000 mg/day).
## Dose Adjustments
- **Hepatic Impairment:** Reduce total daily dose and/or increase dosing interval in patients with active liver disease or alcohol use disorder.
- **Renal Impairment:** Generally 50%–75% of the standard dose interval recommended for severe renal failure (CrCl < 10 mL/min).
## Contraindications
- Known hypersensitivity to acetaminophen.
- Severe active liver disease or severe hepatic impairment.
## Adverse Effects
- Generally well-tolerated.
- Rare but severe: Hepatotoxicity (dose-dependent), serious skin reactions (Stevens-Johnson syndrome, TEN).
## Key Drug Interactions
- **Warfarin:** Chronic, high-dose use may increase the International Normalized Ratio (INR).
- **Hepatotoxic agents:** Concomitant use with alcohol, isoniazid, or other potentially hepatotoxic drugs increases the risk of acetaminophen-induced liver injury.
- **CYP2E1 Inducers:** May increase production of the toxic metabolite NAPQI.
## Monitoring
- **Liver Function Tests (LFTs):** Monitor during long-term therapy or overdose.
- **Dose Tracking:** Ensure total daily intake from all combination products (e.g., opioid-acetaminophen blends) does not exceed limits.
## Clinical Pearls
- NAPQI, the toxic metabolite, is neutralized by glutathione. Toxicity occurs when glutathione is depleted (e.g., overdose or malnutrition).
- Acetylcysteine is the antidote for toxicity; initiate early if overdose is suspected based on the Rumack-Matthew nomogram.
- Always verify the concentration of liquid formulations, as these vary significantly by product, leading to frequent pediatric dosing errors.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult current institutional protocols, official package inserts, or clinical decision support tools (e.g., Lexicomp, Micromedex) before prescribing or administering any medication.